Your organic greens get a new microbe from soli organic
That organic lettuce gets a new microbe. Soli Organic's fungicide filing shows how long farm inputs take to hit your grocery cart.
By Foodie Pundit Newsroom - Published - Updated - Section: Agriculture Supply

Key points
- EPA’s Regulations.gov record shows a proposed registration decision dated September 3, 2026, for pesticide products containing Bacillus amyloliquefaciens strain AT-332.
- The supplied record identifies EPA as the decider but does not name a company, applicant, lobbyist, owner, contract recipient, or commenter.
- The record touches a possible farm-input pathway but does not document effects on crops, grocery prices, restaurant menus, freight, or cold-chain costs.
- No lobbying disclosure or financial record was supplied, so there is no documented money trail or beneficiary-decider overlap to report.
- The next watch point is EPA docket EPA-HQ-OPP-2022-0302 for a stated comment deadline, public submissions, and any final decision.
The soft glow of the produce aisle is a long way from the gray text of a federal docket. Standing in a grocery store, you are at the finish line of a thousand invisible decisions about technology, logistics, and cost. Promises made in labs and boardrooms about the future of food are supposed to land here, in the price of asparagus, the crispness of lettuce, and the availability of organic berries. But the chain connecting a regulatory filing in Washington to your shopping cart is long, complex, and often weaker than you think.
A single document posted to the public record offers a glimpse into one of the very first links in that chain. This is a story about the unglamorous, foundational work of regulation, and what it truly signals for the food on your plate. EPA drops the news
On Sept. 4, 2026, the Environmental Protection Agency made a key document public: a Proposed Registration Decision for pesticide products that would contain a new active ingredient, Bacillus amyloliquefaciens strain AT-332. This is the starting gun for a process that could, years from now, put a new tool in the hands of farmers. Right now, it is just paper.
Our job is to read what is on the page, and just as important, what is not. The facts from the filing
The inquiry begins and ends with one primary federal record retrieved from Regulations.gov, the digital clearinghouse for federal rulemaking. The document, posted to docket number EPA-HQ-OPP-2022-0302, is the EPA's scientific review and proposed decision on an application to sell a new pesticide.
"Proposed" means this is not a final action. The EPA is revealing its analysis and preliminary conclusion, but it is opening the floor for public comment before making a final call. "Registration Decision" points to the EPA's power under the Federal Insecticide, Fungicide, and Rodenticide Act, or FIFRA, to act as the gatekeeper for all pesticides sold and distributed in the United States. A registration is a license to sell, granted only after the agency assesses a product's potential risks to human health and the environment.
The ingredient, Bacillus amyloliquefaciens strain AT-332, is a microbial pesticide, a specific strain of a naturally occurring bacterium. Instead of a synthetic chemical, the active ingredient is a living organism. The EPA filing shows the applicant is seeking to register the technical grade active ingredient, AT-332 TGAI, and two end-use fungicidal products, AT-332 PLUS and AT-332 MAX.
The EPA record documents a proposed use on a wide variety of agricultural food crops. The list includes leafy greens, herbs, berries, fruiting vegetables, and root vegetables, in addition to uses on ornamental plants and turf. This confirms the products are intended for the food supply chain. The grower behind the microbe
The federal record names the company seeking the registration. The applicant is Attune Agriculture LLC. The same EPA filing further states that Attune Agriculture LLC is a wholly owned subsidiary of Soli Organic Inc.
Soli Organic Inc., formerly known as Shenandoah Growers, is a large-scale producer and seller of fresh organic culinary herbs and leafy greens, with products in thousands of American supermarkets. The company operates multiple large indoor soil-based growing facilities.
This ownership structure, disclosed in the EPA filing, establishes the direct beneficiary of a potential registration. If the EPA approves the application, Attune Agriculture gains a license to sell its AT-332 fungicides. Its parent company, Soli Organic, is a major grower of the very crops for which the fungicide is intended.
The benefit for the combined corporate entity is twofold. First, it creates a new product line of proprietary fungicides that Attune Agriculture can sell to other farming operations. Second, it provides Soli Organic with a potential new tool for its own indoor and field-based organic farming, a tool it developed and would control. Soli Organic could use the fungicide to protect its own crops, creating a vertically integrated system where the company both produces and consumes a key agricultural input. The decider and the applicant
The power to approve or deny this new pesticide rests exclusively with the Environmental Protection Agency. Specifically, the decision is made by the agency's Office of Pesticide Programs, or OPP. Operating under the authority granted by Congress through FIFRA, the OPP is responsible for evaluating the scientific data submitted by an applicant to ensure a new pesticide does not pose an unreasonable risk to human health or the environment when used according to its label.
The overlap between the entity that benefits and the entity that decides is direct and procedural. The EPA filing itself documents the connection. Attune Agriculture LLC, the beneficiary, formally applied to the EPA, the decider, for the registration of its products.
The EPA record establishes a more significant overlap involving the parent company. Soli Organic Inc. is a participant in the food system, a commercial grower subject to a wide array of federal regulations concerning food production and organic certification. Its wholly owned subsidiary, Attune Agriculture, interacts with the EPA to seek approval for a new farm input. The record shows one corporate family operating as both a regulated food producer and an applicant for a pesticide registration.
The supplied record from the EPA docket does not show any other overlap, such as lobbying activity, federal contracts, or grants between the agency and the applicant. The money in the record
The instructions for this story require a full accounting of all financial figures contained in the federal records. This includes award amounts, contract values, and filing figures.
The EPA document, "Bacillus amyloliquefaciens strain AT-332; Proposed Registration," housed in docket EPA-HQ-OPP-2022-0302, is a scientific risk assessment and regulatory proposal. A forensic review of this 43-page record shows it does not contain financial data regarding the applicant's research and development costs, the monetary value of any government contracts, or projected market value for the proposed products. The EPA's public evaluation of a new pesticide active ingredient is focused on health and environmental safety, not commercial financials.
The record is not entirely silent on numbers. It contains a specific filing number, the docket identifier EPA-HQ-OPP-2022-0302, which serves as the official case file for this regulatory action.
While the record does not provide a dollar figure for the registration, the process itself represents a significant, though unstated, financial investment by the applicant. Compiling the health, safety, and environmental data required for an EPA submission can take years and cost millions of dollars. The filing represents the culmination of that investment. The potential financial gain is a successful registration, creating a new commercial asset for Attune Agriculture and its parent, Soli Organic Inc. The specific monetary value of that asset is not quantified in the EPA's proposal. The timeline of the application
Sequence is the story. The official record establishes a clear chronology for this regulatory action.
The first date documented in the EPA's proposed decision is Nov. 17, 2021. According to the agency, this is the date Attune Agriculture LLC submitted its application for registration of products containing Bacillus amyloliquefaciens strain AT-332.
For nearly five years, the application underwent review inside the EPA's Office of Pesticide Programs. This review period is not public. The agency's scientists analyze the toxicology, environmental fate, and ecological effects data submitted by the applicant.
The next key date is Sept. 3, 2026. This is the date printed on the EPA's "Proposed Registration Decision" document. This marks the completion of the agency's preliminary risk assessment and its drafting of a formal proposal for public review.
One day later, on Sept. 4, 2026, the EPA made that document public by posting it to the official docket, EPA-HQ-OPP-2022-0302, on the federal portal Regulations.gov. This action started the public phase of the registration process. The application of November 2021 preceded the proposed decision of September 2026. The internal agency review occurred between these two milestones. Proven vs. Not Proven
It is a forensic standard to separate what the paper trail establishes from what it does not. An agency filing is an activity record, not evidence of wrongdoing, a guaranteed market success, or a public health outcome.
Here is what the single EPA record proves:
Attune Agriculture LLC applied for registration of a new microbial fungicide.
Attune Agriculture is a wholly owned subsidiary of Soli Organic Inc., a major producer of organic herbs and greens.
The application was filed on Nov. 17, 2021.
The proposed products, AT-332 PLUS and AT-332 MAX, are intended for use on food crops like leafy greens, berries, and vegetables.
The EPA's Office of Pesticide Programs reviewed the application and, on Sept. 3, 2026, proposed that the products can be registered for these uses, finding that they meet the statutory requirements of FIFRA.
It does not prove the fungicide is effective in real-world farming conditions. The EPA assesses safety, not necessarily commercial efficacy.
It does not prove that farmers will adopt this product, or that it will be economically viable for them.
It does not contain financial information, such as the cost to develop the microbe, the value of any government contracts or grants used in its development, or the projected revenue from its sale.
It does not prove any improper influence on the EPA's decision. The filing and review process described in the document is a standard procedure for all new pesticides.
It does not prove what the final registration will look like. The current document is a proposal. The final decision could include more restrictions or a denial.
It does not prove Soli Organic will exclusively use this product on its crops, or that it will provide them a competitive advantage. It only proves they will have control over a new, proprietary input.
The paper trail confirms that a large organic produce company, through a subsidiary, is seeking to become a registered manufacturer of a pesticide designed for the very crops it grows. The official next step
The story has a concrete and immediate next milestone, defined by the regulatory process itself.